title: Immunoreactive inhibin-production in post-menopausal women with malignant epithelial ovarian tumors.
abstract: In post-menopausal women with a malignant epithelial ovarian tumor the follicle stimulating hormone (FSH) level was found to be significantly lower compared with healthy controls. We demonstrated immunoreactive (i.r.) inhibin in 20% of controls which was elevated to 60% of women with an ovarian tumor and correlating strongly to FSH in the tumor group (P = 0.0002). Steroid hormone levels were comparable in the two groups. In women with ovarian tumors the survival time for the i.r. inhibin-producing women was found to be 4.6 years compared with 0.9 year, or 5.1 times longer than in the non-producing women (P = 0.002). The site of i.r. inhibin production in these post-menopausal women is unknown, but i.r. inhibin production by the developing ovarian tumor or by the post-menopausal ovary may be regarded as a defense mechanism against an elevated gonadotrophin level (the gonadotrophin theory) which would promote further tumor growth. The recent suggestion that the alpha subunit of inhibin is a tumor suppressor gene is consistent with these results. The serum i.r. inhibin or alpha subunit concentrations might be used as an aid to diagnosis or as a prognostic indicator of survival in women with an ovarian carcinoma.
authors.affiliation: Department of Obstetrics and Gynecology, Rigshospitalet, Copenhagen, Denmark.
authors.forename: J
authors.initials: J
authors.lastname: Blaakaer
authors.forename: S
authors.initials: S
authors.lastname: Micic
authors.forename: I D
authors.initials: ID
authors.lastname: Morris
authors.forename: U
authors.initials: U
authors.lastname: Hørding
authors.forename: P
authors.initials: P
authors.lastname: Bennett
authors.forename: K
authors.initials: K
authors.lastname: Toftager-Larsen
authors.forename: H
authors.initials: H
authors.lastname: Djursing
authors.forename: J E
authors.initials: JE
authors.lastname: Bock
mesh_terms: D000368:Aged; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006062:Gonadotropins / Q000097:blood; D006801:Humans; D007124:Immunoenzyme Techniques; D007265:Inhibins / Q000096:biosynthesis* / Q000097:blood; D008875:Middle Aged; D009375:Neoplasms, Glandular and Epithelial / Q000097:blood*; D010051:Ovarian Neoplasms / Q000097:blood*; D017698:Postmenopause / Q000097:blood*; D012016:Reference Values; D013256:Steroids / Q000097:blood
chemical_list: D006062:Gonadotropins; D013256:Steroids; D007265:Inhibins; D005640:Follicle Stimulating Hormone